As of February 2026 Inhibrx Biosciences has a market cap of A$1.72 Billion. This makes Inhibrx Biosciences the world's 5698th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Feb 4th, 2026 the market cap of Inhibrx Biosciences was reported to be: